Reports for APOTEX INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

257 (7%)

Anticipated shortage:

3 (0%)

Avoided shortage:

11 (0%)

Resolved:

3300 (92%)

3571

Discontinuation Reports

To be discontinued:

24 (7%)

Discontinued:

342 (93%)

Reversed:

0 (0%)

366

143 (4%)

32 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2024-08-29 2024-11-01 236261
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-11-26 2020-12-17 128933
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2018-01-22 2018-06-12 36817
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2024-10-04 2025-01-10 239373
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2025-01-30 2025-03-28 249074
APO-GLIMEPIRIDE 2MG TABLET Resolved 2018-07-11 2019-09-21 55281
APO-GLIMEPIRIDE 4MG TABLET Resolved 2017-11-28 2019-09-21 31007
APO-GLIMEPIRIDE 1MG TABLET Resolved 2017-12-12 2019-09-21 32536
APO-GUANFACINE XR 3MG TABLET (EXTENDED-RELEASE) Resolved 2022-06-12 2022-07-28 162475
APO-GUANFACINE XR 3MG TABLET (EXTENDED-RELEASE) Resolved 2024-12-12 2025-01-17 245499
APO-GUANFACINE XR 4MG TABLET (EXTENDED-RELEASE) Resolved 2025-09-04 2025-09-12 266649
APO-GUANFACINE XR 3MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-22 2024-01-12 214220
APO-GUANFACINE XR 4MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-22 2022-08-06 165322
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-08 2024-01-12 212949
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2025-06-26 2025-07-04 261170
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-01-12 206579
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-11 2022-08-12 164378
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2024-12-12 2025-01-17 245496
APO-GUANFACINE XR 4MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-15 2024-01-12 213559
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-06 2024-01-12 209339
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO PEN VK Discontinued 2019-03-08 2019-03-08 78141
APO PEN VK Discontinued 2019-03-08 2019-03-08 78144
APO PREDNISONE TAB 1MG USP 1MG TABLET Discontinued 2017-03-13 2017-03-13 1056
APO PREDNISONE TAB 5MG 5MG TABLET Discontinued 2018-09-08 2018-12-28 60699
APO TRIAZIDE 50MG 25MG TABLET Discontinued 2018-09-08 2019-02-13 60837
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE 300MG 150MG 300MG TABLET Discontinued 2022-12-12 2022-12-12 177953
APO-ACEBUTOLOL 400MG TABLET Discontinued 2017-03-31 2018-02-05 4965
APO-ACETAMINOPHEN CAPLETS 500MG 500MG TABLET Discontinued 2018-09-07 2018-09-08 60157
APO-ALENDRONATE 5MG TABLET Discontinued 2019-01-03 2019-12-21 71023
APO-ALENDRONATE 10MG TABLET To be discontinued 2018-09-07 2019-12-20 60163
APO-ALENDRONATE 10MG TABLET To be discontinued 2019-01-03 2019-12-20 71026
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83971
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83976
APO-AMITRIPTYLINE 75MG TABLET To be discontinued 2025-01-10 2025-01-10 247472
APO-AMITRIPTYLINE 25MG TABLET Discontinued 2025-01-10 2025-01-11 247466
APO-AMITRIPTYLINE 50MG TABLET To be discontinued 2019-01-04 2021-06-05 71354
APO-AMITRIPTYLINE 10MG TABLET Discontinued 2025-01-10 2025-01-11 247462
APO-AMITRIPTYLINE 50MG TABLET To be discontinued 2025-01-10 2025-01-27 247469
APO-AMITRIPTYLINE 25MG TABLET Discontinued 2019-01-04 2019-02-13 71351
APO-AMITRIPTYLINE 10MG TABLET Discontinued 2019-01-04 2019-01-04 71348